Encoding cancer antigen 125 (CA125), MUC16 is frequently mutated and highly related to the prognosis in various tumors, including cholangiocarcinoma (36–39), ovarian carcinoma, hepatocellular carcinoma, and GC. Here, MUC16 is linked to cholangiocarcinoma.